 |
 |

Changes in Methadone Treatment Practices
Results From a National Panel Study, 1988-2000
Thomas D'Aunno, PhD;
Harold A. Pollack, PhD
JAMA. 2002;288:850-856.
Context Results from several studies conducted in the early 1990s showed that the majority of US methadone maintenance programs did not use treatment practices that met established standards for the care of heroin users. Effective treatment for heroin users is critical given the upsurge in heroin use and the continued role of injection drug use in the human immunodeficiency virus and hepatitis C epidemics.
Objectives To examine the extent to which US methadone maintenance treatment programs have made changes in the past 12 years to provide adequate methadone doses and to identify factors associated with variation in program performance.
Design, Setting, and Participants Program directors and clinical supervisors of nationally representative methadone treatment programs that varied by ownership (for-profit, public, or private not-for-profit) and setting (eg, free-standing, hospital-based) were surveyed in 1988 (n = 172), 1990 (n = 140), 1995 (n = 116), and 2000 (n = 150).
Main Outcome Measures Percentage of patients in each treatment program receiving methadone dosages of less than 40, 60, and 80 mg/d.
Results The percentage of patients receiving methadone dosage levels less than the recommended 60 mg/d has decreased from 79.5% in 1988 to 35.5% in 2000. Results also show that programs with a greater percentage of African American patients are especially likely to dispense low dosages, while programs with Joint Commission on Accreditation of Healthcare Organizations accreditation are more likely to provide adequate methadone doses.
Conclusions Efforts to improve methadone treatment practices appear to be making progress, but many patients are still receiving substandard care.
Author Affiliations: School of Social Service Administration and Department of Health Studies, University of Chicago (Dr D'Aunno), and Department of Health Management and Policy, School of Public Health (Dr Pollack), University of Michigan, Ann Arbor. Dr D'Aunno is now with INSEAD, Fontainebleau, France.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Can Psychiatry Cross the Quality Chasm? Improving the Quality of Health Care For Mental and Substance Use Conditions
Pincus et al.
Am. J. Psychiatry 2007;164:712-719.
ABSTRACT
| FULL TEXT
Pharmacokinetic Interaction between Voriconazole and Methadone at Steady State in Patients on Methadone Therapy
Liu et al.
Antimicrob. Agents Chemother. 2007;51:110-118.
ABSTRACT
| FULL TEXT
Treatment of Heroin Dependence: Effectiveness, Costs, and Benefits of Methadone Maintenance
Schilling et al.
Research on Social Work Practice 2006;16:48-56.
ABSTRACT
Methods of Detoxification and Their Role in Treating Patients With Opioid Dependence
O'Connor
JAMA 2005;294:961-963.
FULL TEXT
Medication Development for Addictive Disorders: The State of the Science
Vocci et al.
Am. J. Psychiatry 2005;162:1432-1440.
ABSTRACT
| FULL TEXT
Methadone Maintenance in a Men's Prison in Puerto Rico: A Pilot Program
Heimer et al.
J Correct Health Care 2005;11:295-305.
ABSTRACT
Factors Associated With Illegal Drug Use Among Older Methadone Clients
Rosen
Gerontologist 2004;44:543-547.
ABSTRACT
| FULL TEXT
Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT
| FULL TEXT
|